• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

双心室血管内微轴血泵与免疫抑制作为巨细胞性心肌炎恢复的桥梁

Biventricular Intravascular Microaxial Blood Pumps and Immunosuppression as a Bridge to Recovery in Giant Cell Myocarditis.

作者信息

Ma Janet I, Ammirati Enrico, Brambatti Michela, Adler Eric

机构信息

Division of Cardiology, Department of Medicine, University of California, Sulpizio Cardiovascular Center, San Diego, California.

Transplant Center and De Gasperis Cardio Center, Niguarda Hospital, Milano, Italy.

出版信息

JACC Case Rep. 2020 Aug 19;2(10):1484-1488. doi: 10.1016/j.jaccas.2020.05.107. eCollection 2020 Aug.

DOI:10.1016/j.jaccas.2020.05.107
PMID:34317002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8302165/
Abstract

We report a case of giant cell myocarditis in a 76-year-old patient managed with combined immunosuppression and biventricular intravascular microaxial blood pumps. This case highlights a feasible approach for managing such patients who are not candidates for transplantation or durable ventricular assist devices. ().

摘要

我们报告了一例76岁巨细胞心肌炎患者，采用免疫抑制联合双心室血管内微轴血泵进行治疗。该病例突出了一种针对不适合移植或持久心室辅助装置的此类患者的可行管理方法。（）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/58e74515d321/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/4dfe834e7781/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/82ab525a5bc4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/58e74515d321/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/4dfe834e7781/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/82ab525a5bc4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/8302165/58e74515d321/gr2.jpg

相似文献

1
Biventricular Intravascular Microaxial Blood Pumps and Immunosuppression as a Bridge to Recovery in Giant Cell Myocarditis.双心室血管内微轴血泵与免疫抑制作为巨细胞性心肌炎恢复的桥梁
JACC Case Rep. 2020 Aug 19;2(10):1484-1488. doi: 10.1016/j.jaccas.2020.05.107. eCollection 2020 Aug.
2
Spontaneous Remission in a Case of Giant Cell Myocarditis with Preserved Left Ventricular Ejection Fraction.左心室射血分数保留的巨细胞性心肌炎患者的自发缓解
Am J Case Rep. 2015 Nov 19;16:823-6. doi: 10.12659/ajcr.895253.
3
Recurrent giant cell myocarditis after heart transplant: a case report.心脏移植术后复发性巨细胞性心肌炎：一例报告
Eur Heart J Case Rep. 2022 Sep 5;6(9):ytac362. doi: 10.1093/ehjcr/ytac362. eCollection 2022 Sep.
4
Different reverse remodelling between left ventricle and right ventricle in fulminant heart failure due to giant cell myocarditis: a case report.巨细胞性心肌炎所致暴发性心力衰竭时左心室与右心室不同的逆向重构：一例报告
Eur Heart J Case Rep. 2021 Aug 23;5(8):ytab214. doi: 10.1093/ehjcr/ytab214. eCollection 2021 Aug.
5
The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis.右心室心内膜活检在特发性巨细胞性心肌炎中的作用
J Card Fail. 2002 Apr;8(2):74-8. doi: 10.1054/jcaf.2002.32196.
6
Fulminant Eosinophilic Myocarditis: A Rare and Life-Threatening Presentation of Eosinophilic Granulomatosis With Polyangiitis.暴发性嗜酸性粒细胞性心肌炎：嗜酸性肉芽肿性多血管炎的一种罕见且危及生命的表现形式。
JACC Case Rep. 2020 May 20;2(5):802-808. doi: 10.1016/j.jaccas.2020.01.031. eCollection 2020 May.
7
Fulminant cardiac sarcoidosis resembling giant cell myocarditis: a case report.酷似巨细胞心肌炎的暴发性心脏结节病：一例报告
Eur Heart J Case Rep. 2021 Mar 10;5(3):ytab042. doi: 10.1093/ehjcr/ytab042. eCollection 2021 Mar.
8
Progressive Thinning of the Basal Interventricular Septum by Giant Cell Myocarditis.巨细胞性心肌炎致室间隔基底部进行性变薄
JACC Case Rep. 2020 Jan 22;2(2):180-185. doi: 10.1016/j.jaccas.2019.11.036. eCollection 2020 Feb.
9
Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report.使用双心室辅助装置成功实现暴发性心肌炎的康复过渡：一例病例报告。
J Med Case Rep. 2017 Oct 24;11(1):295. doi: 10.1186/s13256-017-1466-1.
10
Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience.心脏结节病和巨细胞心肌炎的诊断、治疗和转归：瑞典单中心经验。
BMC Cardiovasc Disord. 2022 Apr 26;22(1):192. doi: 10.1186/s12872-022-02639-0.

引用本文的文献

1
Temporary mechanical circulatory support as a bridge to durable left ventricular assist device as destination therapy in fulminant giant cell myocarditis：A case report.临时机械循环支持作为通向持久左心室辅助装置的桥梁用于暴发性巨细胞性心肌炎的终末期治疗：一例报告
Heliyon. 2024 Jun 1;10(12):e32324. doi: 10.1016/j.heliyon.2024.e32324. eCollection 2024 Jun 30.
2
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).心源性休克研究和机械循环支持设备的标准化定义：休克学术研究联盟（SHARC）的科学专家小组。
Circulation. 2023 Oct 3;148(14):1113-1126. doi: 10.1161/CIRCULATIONAHA.123.064527. Epub 2023 Oct 2.
3

本文引用的文献

1
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction.暴发性与非暴发性急性心肌炎患者的左心室收缩功能障碍。
J Am Coll Cardiol. 2019 Jul 23;74(3):299-311. doi: 10.1016/j.jacc.2019.04.063.
2
Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts.机械性心肌卸载：LV-IMPELLA、ECMELLA、BI-PELLA 和 PROPELLA 概念。
J Cardiovasc Transl Res. 2019 Apr;12(2):116-123. doi: 10.1007/s12265-018-9820-2. Epub 2018 Aug 6.
3
Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort.
Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.
急性心肌炎和复发性/急性心包炎的免疫调节治疗
Front Med (Lausanne). 2022 Mar 7;9:838564. doi: 10.3389/fmed.2022.838564. eCollection 2022.
4
Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation.暴发性巨细胞性心肌炎需要借助机械循环支持过渡到心脏移植。
JACC Case Rep. 2022 Mar 2;4(5):265-270. doi: 10.1016/j.jaccas.2021.11.013.
5
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.急性心肌炎和慢性炎症性心肌病的管理：专家共识文件。
Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12.
6
Giant Cell Myocarditis: Still the Deadly Giant.巨细胞性心肌炎：仍是致命的“巨人”
JACC Case Rep. 2020 Aug;2(10):1489-1491. doi: 10.1016/j.jaccas.2020.07.001. Epub 2020 Aug 19.
机械循环支持下暴发性巨细胞心肌炎：法国多中心队列的管理和结局。
Int J Cardiol. 2018 Feb 15;253:105-112. doi: 10.1016/j.ijcard.2017.10.053.
4
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.暴发性与非暴发性急性心肌炎的生存和左心室功能变化。
Circulation. 2017 Aug 8;136(6):529-545. doi: 10.1161/CIRCULATIONAHA.117.026386. Epub 2017 Jun 2.
5
Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis.兔抗胸腺细胞球蛋白在巨细胞性心肌炎患者中的应用价值
Am J Cardiol. 2015 Aug 1;116(3):447-51. doi: 10.1016/j.amjcard.2015.04.040. Epub 2015 May 8.
6
Giant cell myocarditis successfully treated with antithymocyte globuline and extracorporeal membrane oxygenation for 21 days.巨细胞性心肌炎经抗胸腺细胞球蛋白和体外膜肺氧合治疗21天成功治愈。
J Cardiovasc Med (Hagerstown). 2016 Dec;17 Suppl 2:e151-e153. doi: 10.2459/JCM.0000000000000250.
7
Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.联合免疫抑制时代的巨细胞心肌炎的诊断、治疗和结局。
Circ Heart Fail. 2013 Jan;6(1):15-22. doi: 10.1161/CIRCHEARTFAILURE.112.969261. Epub 2012 Nov 13.
8
Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.特发性巨细胞性心肌炎——自然病程与治疗。多中心巨细胞性心肌炎研究组研究者
N Engl J Med. 1997 Jun 26;336(26):1860-6. doi: 10.1056/NEJM199706263362603.